ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)
Clinical trial NCT03788837 · COMPLETED
Trial details
- NCT number
- NCT03788837
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2024-01-05
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.